Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05036616
Other study ID # IRB.151/64
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date December 31, 2023

Study information

Verified date July 2023
Source Chulalongkorn University
Contact Sasipha tachaboon
Phone 6622564000
Email sasipha_tac@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This investigation aims to evaluate the filter life time of CRRT membrane and complication of combining ECMO and CRRT.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: 1. > 18 years 2. Refractory acidosis (pH<7.2 or HCO3<15) 3. Refractory volume overload 4. Refractory hyperkalemia (K>6.2mEq/L or EKG change) 5. Anuria or oliguria (urine output <0.5 mL/kg/hr for 6-12hr) 6. High BUN >100 mg/dL or uremic symptom 7. Increase intracranial pressure Exclusion Criteria: 1. Pregnancy 2. Not use heparin in ECMO 3. Chronic kidney disease with CRRT 4. AKI with Glomerulonephritis, Interstitial nephritis, Vassculitis or Urinary tract obstruction

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy
Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy

Locations

Country Name City State
Thailand Sasipha tachaboon Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Chulalongkorn University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Circuit lifetime The time until a CVVH malfunction was identified 72 hours
Secondary Cost-Effectiveness To evaluate the cost utility of CRRT between 2 groups 72 hours
See also
  Status Clinical Trial Phase
Completed NCT04112953 - Intraoperative Transesophageal Echocardiography Assessment of Portal Vein Flow and Renal Resistive Index As a Predictor of Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Study
Completed NCT04395911 - Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections N/A
Terminated NCT04530448 - Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization Phase 4
Active, not recruiting NCT04008810 - Serum Neutrophil Gelatinase-associated Lipocalins (NGAL) and Chronic Kidney Disease
Recruiting NCT04597034 - Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 N/A
Completed NCT04458571 - Effect of CRRT Duration on Solute Removal
Recruiting NCT04114747 - Renal Physiology During Continuous Renal Replacement Therapy N/A
Completed NCT05094154 - Effect of Antibiotic Choice On ReNal Outcomes (ACORN) Phase 4
Enrolling by invitation NCT04491227 - Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
Not yet recruiting NCT05382078 - Nafamostat Mesilate for Anticoagulation During CRRT in Critically Ill Patients
Recruiting NCT04351906 - Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome N/A
Completed NCT04762524 - The Impact of CRRT Modality on Filter Life N/A
Completed NCT04048525 - Cytokine Removal With CVVHD Compared to CVVH N/A
Completed NCT04788394 - Renal Involvement in Hospitalized Children With COVID-19
Recruiting NCT04474249 - Follow-up of Critical COVID-19 Patients
Recruiting NCT04517630 - Renal Biomarkers in AKI and COVID-19
Completed NCT04407156 - Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom
Recruiting NCT04895384 - El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)
Completed NCT03070353 - Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury Phase 2/Phase 3
Completed NCT03391830 - Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy N/A